BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36740561)

  • 21. [Predictive value of N-terminal B-type natriuretic peptide on outcome of elderly hospitalized non-heart failure patients].
    Li YY; Liang YD; Yao SM; Zheng PP; Zeng XZ; Cui LL; Guo D; Wang H; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):661-668. PubMed ID: 32847322
    [No Abstract]   [Full Text] [Related]  

  • 22. Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients.
    Eriguchi M; Tsuruya K; Lopes M; Bieber B; McCullough K; Pecoits-Filho R; Robinson B; Pisoni R; Kanda E; Iseki K; Hirakata H
    ESC Heart Fail; 2022 Apr; 9(2):1138-1151. PubMed ID: 35026869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.
    van Peet PG; de Craen AJ; Gussekloo J; de Ruijter W
    Age (Dordr); 2014 Jun; 36(3):9660. PubMed ID: 24807464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements.
    Gutiérrez OM; Tamez H; Bhan I; Zazra J; Tonelli M; Wolf M; Januzzi JL; Chang Y; Thadhani R
    Clin Chem; 2008 Aug; 54(8):1339-48. PubMed ID: 18539645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Tofte N; Theilade S; Winther SA; Birkelund S; Goetze JP; Hansen TW; Rossing P
    Diabetes Care; 2021 Feb; 44(2):595-603. PubMed ID: 33323477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study.
    Lorgis L; Zeller M; Dentan G; Sicard P; Buffet P; L'Huillier I; Beer JC; Vincent-Martin M; Makki H; Gambert P; Cottin Y;
    BMJ; 2009 May; 338():b1605. PubMed ID: 19420032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population.
    Ciardullo S; Rea F; Cannistraci R; Muraca E; Perra S; Zerbini F; Mortara A; Perseghin G
    Cardiovasc Diabetol; 2022 Nov; 21(1):236. PubMed ID: 36344968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
    Costacou T; Saenger AK; Orchard TJ
    Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal pro-brain natriuretic peptide and cardiovascular or all-cause mortality in the general population: A meta-analysis.
    Geng Z; Huang L; Song M; Song Y
    Sci Rep; 2017 Jan; 7():41504. PubMed ID: 28134294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
    Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
    Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The joint association of diabetes status and NT-ProBNP with adverse cardiac outcomes in patients with non-ST-segment elevation acute coronary syndrome: a prospective cohort study.
    Wang M; Su W; Chen H; Li H
    Cardiovasc Diabetol; 2023 Mar; 22(1):46. PubMed ID: 36871021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk.
    Klein Hesselink EN; van der Horst-Schrivers ANA; van der Horst ICC; Bakker SJL; Muller Kobold AC; Brouwers AH; de Bock GH; Gietema JA; Dullaart RPF; Links TP; Lefrandt JD
    Clin Biochem; 2017 Aug; 50(12):696-702. PubMed ID: 28242284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of adiponectin and amino terminal proBNP in peripheral arterial disease.
    Dieplinger B; Poelz W; Haltmayer M; Mueller T
    Clin Chim Acta; 2007 Feb; 377(1-2):192-7. PubMed ID: 17112494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of women.
    Everett BM; Berger JS; Manson JE; Ridker PM; Cook NR
    J Am Coll Cardiol; 2014 Oct; 64(17):1789-97. PubMed ID: 25443700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
    J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.
    Shafi T; Zager PG; Sozio SM; Grams ME; Jaar BG; Christenson RH; Boulware LE; Parekh RS; Powe NR; Coresh J
    Am J Kidney Dis; 2014 Sep; 64(3):443-51. PubMed ID: 24787760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.
    Stamm JA; Belloli EA; Zhang Y; Bon J; Sciurba FC; Gladwin MT
    PLoS One; 2011; 6(11):e27416. PubMed ID: 22087311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.